3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Renal Cell
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Interventions
Specimen Handling
3
Biopsy
3
X-Rays
2
Standard of Care
2
Practice Guidelines as Topic
2
Interviews as Topic
2
trastuzumab biosimilar HLX02
1
pertuzumab
1
erdafitinib
1
copanlisib
1
Trastuzumab
1
Palliative Care
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Methods
1
Magnetic Resonance Spectroscopy
1
Health Promotion
1
Educational Status
1
Early Intervention, Educational
1
CT-P6
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Malignant Solid Neoplasm
×
Early Intervention, Educational
×
30 days
×
Clear all
NCT06541158
2026-05-28
TRACT
Emory University
Phase NA
Recruiting
76 enrolled